U.S. Senate Appropriations Report Further Validates Adial’s Therapeutic Approach and Promotes a More Contemporary Patient Focused Regulatory EnvironmentGLEN ALLEN, Va.,...
The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S. mental health providers to help...
After a successful pilot, Dismas Charities partners with The Change Companies to bring individualized, digital-first programming to justice-involved individuals. CARSON...
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4...
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed,...
DEA Administrator Terrance Cole has also signaled a tough line: "Everybody knows my stance on marijuana after 30 plus years...
We're Out of Time Podcast Host & Addiction Recovery Expert Richard Taite Endorses Bereaved Parents' Nationwide, In-School Fentanyl Prevention Effort...
GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory ApprovalReceives $5.3 Million Installment...
- Revenue of $1.9 Million consistent with the year-ago period- Revenue led by Population Health's growth up 197% compared to...
Manuscript accepted for publication in Frontiers in Pharmacology, "Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in...
Acquisition Poised to Drive Substantial Shareholder Value Through Innovative Technologies, Projected Multi-Million Revenues, and Strategic Leadership Alignment: Amin Janmohamed Steps...
LAGUNA NIGUEL, Calif., Aug. 7, 2025 /PRNewswire/ -- Alleva, the premier EMR platform for behavioral health, proudly announces the release...
Pulse Engagement Cloud and Tris Pharma to partner for smarter, centralized marketing intelligence across ADHD portfolio of products. GARDEN CITY,...
Center City, Minnesota--(Newsfile Corp. - July 31, 2025) - Hazelden Betty Ford Foundation, the nation's leading nonprofit system of addiction...
BURLINGTON, Mass. and JERUSALEM, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
Strategic Acquisition Positions Branded Legacy to Enter the Growing Naloxone and Vaccine Markets, Enhancing Shareholder Value; Leadership Transition Planned with...
Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company,...
SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...